Søren Johan Brun
Copenhagen, December 2021
Brain+ lands partnership with Roche for entry in Germany 2 years ahead of plan.
“Brain+ has signed a partnership agreement with RoX Health (https://roxhealth.com/), a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.”
Read more about the partnership HERE.
Brain+ was Gemstone Capital’s IPO company #12 (2021)
